Kolon Life Science (XKRX:102940) 3-Year EBITDA Growth Rate : 11.50% (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Kolon Life Science 3-Year EBITDA Growth Rate?

Kolon Life Science's EBITDA per Share for the three months ended in Mar. 2024 was ₩478.77.

During the past 12 months, Kolon Life Science's average EBITDA Per Share Growth Rate was -162.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 11.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Kolon Life Science was 26.70% per year. The lowest was -26.00% per year. And the median was 7.60% per year.

Competitive Comparison of Kolon Life Science's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Kolon Life Science's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kolon Life Science's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kolon Life Science's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Kolon Life Science's 3-Year EBITDA Growth Rate falls into.

Kolon Life Science 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Kolon Life Science (XKRX:102940) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Kolon Life Science 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Kolon Life Science's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Kolon Life Science (XKRX:102940) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kolon Life Science Inc (XKRX:102940) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

110, Magokdong-ro, Gangseo-gu, One & Only Tower, Seoul, KOR

Website

http://www.kolonls.co.kr

Kolon Life Science Inc develops, manufactures and sells Biopharmaceuticals, Active pharmaceutical ingredients, Antimicrobials and Water solutions. Its products include Invossa, KLS-1010, KLS-2020, Azilsartan, Besfloc etc. The company has manufacturing facilities in Chungju, Eumsung and Kimchun.

Kolon Life Science (XKRX:102940) Headlines

No Headlines